Extraction of Impacted 3rd Molars, Can Bone Support of the Second Molar be Promoted by a Bio-Oss Graft?
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
A prospective study examining bilateral 3rd molar extraction, by a split mouth protocol the investigators augment unilaterally and compare periodontal parameters in between.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2016
CompletedFirst Posted
Study publicly available on registry
April 27, 2016
CompletedStudy Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedApril 27, 2016
March 1, 2016
1 year
March 20, 2016
April 25, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Mobility (Scale 0,1,2,3), change is being assessed.
Mobility will be assessed in the intervals mentioned above, and compared over time.
Pre opp (base line), 1 month post opp, 3 months post opp, 6 months post opp
Pocket Depth (mm), change is being assessed.
Pocket depth will be assessed in the intervals mentioned above, and compared over time.
Pre opp (base line), 1 month post opp, 3 months post opp, 6 months post opp
Study Arms (1)
3rd molar
EXPERIMENTALDrug: Geistlich Bio Oss
Interventions
Eligibility Criteria
You may qualify if:
- Bilateral impacted 3rd molars.
- Healthy individuals
You may not qualify if:
- Smokers
- Alcohol abusers
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Baruch Padeh Medical Center, Poriyalead
- Geistlich Pharma AGcollaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2016
First Posted
April 27, 2016
Study Start
February 1, 2017
Primary Completion
February 1, 2018
Study Completion
February 1, 2019
Last Updated
April 27, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share